Israel's Eltek Q4 revenue rises 22% yr/yr

Reuters
Mar 09
Israel's Eltek Q4 revenue rises 22% yr/yr

Overview

  • Israel-based PCB maker's Q4 revenue rose 22% yr/yr

  • Company faced operational challenges due to manufacturing transformations and currency fluctuations

  • Strategic investments aim to align with growing demand in defense and medical sectors

Outlook

  • Company aligns capital expenditures with growing demand in defense and medical sectors

  • Eltek invests in new plating lines to expand capacity and support complex products

  • Company sees sustained demand for advanced HDI and rigid-flex solutions

Result Drivers

  • MANUFACTURING TRANSFORMATION - Eltek faced operational challenges due to relocating production systems and upgrading machinery for new plating lines

  • CURRENCY IMPACT - Depreciation of U.S. dollar against Israeli shekel increased operating expenses by $2.2 mln

  • STRATEGIC INVESTMENTS - Investments in new plating lines and infrastructure aim to expand capacity and support demand in defense and medical sectors

Company press release: ID:nPn8Bs3MZa

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

$13.24 mln

Q4 Net Income

-$310,000

Q4 EBITDA

$700,000

Q4 Gross Profit

$1.16 mln

Q4 Operating Income

$116,000

Q4 Pretax Profit

-$363,000

Analyst Coverage

  • The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 8 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10